LYEL vs PRLD: stock comparison and AI forecast
Lyell Immunopharma, Inc. (LYEL) and Prelude Therapeutics Inc (PRLD) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
LYEL Lyell Immunopharma, Inc.
- Market Cap
- $368M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
PRLD Prelude Therapeutics Inc
- Market Cap
- $373M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- LYEL and PRLD have similar market capitalizations ($368M and $373M).
- PRLD turns -269.8% of its revenue into net income, against -1701066.7% for LYEL.
- LYEL carries 0.42 times debt per unit of equity, against 0.42 times for PRLD.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | LYEL | PRLD |
|---|---|---|
| Market Cap | $368M | $373M |
| P/B Ratio | 1.91x | 2.79x |
| EPS | $-12.32 | $-1.02 |
| Book Value/Share | $7.86 | $1.46 |
| Revenue/Share | $0.00 | $0.25 |
| FCF/Share | $-5.71 | $-0.36 |
Profitability & Margins
| Metric | LYEL | PRLD |
|---|---|---|
| ROE | -132.4% | -45.2% |
| ROA | -93.2% | -31.9% |
| ROIC | -117.6% | -44.5% |
| Operating Margin | -1783580.0% | -300.6% |
| Net Margin | -1701066.7% | -269.8% |
| EBT Margin | -1783580.0% | -278.0% |
Financial Health
| Metric | LYEL | PRLD |
|---|---|---|
| Current Ratio | 4.02x | 4.07x |
| D/E Ratio | 0.42x | 0.42x |
| Financial Leverage | 1.42x | 1.42x |
| Working Capital | $140M | $117M |
Cash Flow
| Metric | LYEL | PRLD |
|---|---|---|
| Operating Cash Flow | -$139M | -$33M |
| Free Cash Flow | -$140M | -$33M |
| Capital Spending | -$710K | $0.00M |
| FCF/Sales | -933100.0% | -148.3% |
| CapEx/Sales | 4766.7% | 0.0% |
Operational Efficiency
| Metric | LYEL | PRLD |
|---|---|---|
| Asset Turnover | 0.00x | 0.12x |
| Fixed Assets Turnover | 0.0x | 5.1x |
Income Statement
| Metric | LYEL | PRLD |
|---|---|---|
| Total Revenue | $10K | $22M |
| Operating Income | -$268M | -$67M |
| Net Income | -$255M | -$60M |
| R&D Expense | $169M | $69M |
Dividend & Shareholder Information
| Metric | LYEL | PRLD |
|---|---|---|
| Shares Outstanding | 25M | 91M |
LYEL vs PRLD: stock comparison and AI forecast
Which is bigger, LYEL or PRLD?
LYEL and PRLD have similar market capitalizations ($368M and $373M).
Which one does Intratio's AI model rank higher, LYEL or PRLD?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.